NDAQ:ZLAB) Zai Lab Receives Orphan Drug Designation from the U.S. FDA for ZL-1310 (DLL3 ADC) for the Treatment of Small Cell ...

One of the earliest proponents of evidence-based medicine, Professor David Sackett, wrote, “Good doctors use both individual ...

Michael Amoroso, the President and CEO of Precision BioSciences Inc . (NASDAQ:DTIL), has recently sold shares in the company. According to a filing with the Securities and Exchange Commission, Amoroso ...

The filing also noted Smith's indirect ownership of 7,931 shares through a Charitable Remainder Unitrust. The company's market capitalization stands at $38.08 million, with a P/E ratio of 3.28, ...

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...

Insilico Medcine( "Insilico") , a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced the first patient has been dosed in the global multicenter Phase I ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Safety: Aspirin was well-tolerated, with no major safety concerns reported. The ASCOLT trial showed that aspirin did not ...

Sanford Health is teaming up with Medtronic to test a procedure aimed at reducing medication dependency for high blood ...

When compared with reference aflibercept, a biosimilar ranibizumab showed to be a clinically effective and cost-saving ...

Nuvalent, Inc. shares have fallen approximately 30% after promising updates on its two lead NSCLC candidates rallied the stock to all-time highs. Read the full report on the stock here.